Cases of Myopia (near-sightedness) have doubled since the 1960s and will double again by 2050 according to the WHO. Now … continue reading “Myopia in Childhood: Screens to Blame”
Ophthalmics
Precise Bio to Launch Dedicated Ophthalmology Business Unit
Company chooses AAO 2018 at which to announce the launch of its new business
New Contact Lens Coating Promises to Dramatically Reduce Lens Discomfort
Tangible Science, LLC is launching its new Hydra-PEG contact lens coating technology at the Global Specialty Lens Symposium in Las Vegas
New Study Points to Meaningful and Sustained Intraocular Pressure Reduction with Glaukos iStent®
Case series of 42 Pseudophakic eyes shows mean medicated intraocular pressure decrease of 6.64 mm Hg in 21 eyes at two years
CE Mark and Launch for Eyenuk’s Next Generation EyeArt™ Fully Automated Diabetic Retinopathy Screening Software
New Study of 59,000 patients, presented at EASDec 2016, showed EyeArt 2.0 demonstrating 91 Percent Sensitivity and 90.8 Percent Specificity
UK Study Finds Eyeart™ Most Sensitive Analysis Technology for Diabetic Retinopathy Screening
Automated system increases capability and enhances screening sensitivity
CE Mark for Mynosys ZEPTO Capsulotomy Device
Device promises 360 degree simultaneous capsulotomy in milliseconds
Allergan to Acquire Glaucoma Treatment Company AqueSys
Acquisition adds global rights to XEN45, a minimally invasive implantable shunt for Glaucoma
Patient Enrollment Complete in U.S. Pivotal Clinical Trial for Glaukos iStent inject®
New iStent derivative aiming to be smallest device ever approved by FDA
BioLight and Ora, Inc. Expand Collaboration on TeaRx™ Dry Eye Syndrome Test
Test for Dry Eye Syndrome targeted by newly expanded collaboration which aims to accelerate US clearance
First-of-its-Kind Approval for Near Vision Corneal Implant
The U.S. FDA has approved the first implantable device for correction of near vision in patients who have not had cataract surgery
Eye Disease Company Looks to China with New Partnership
BioLight Life Sciences is to enter a strategic partnership that will significantly advance its prospects in the Chinese market
New Diagnostic Test for Dry Eye Syndrome Passes First Clinical Test
A newly completed U.S. clinical study might pave the way for a new diagnostic test for dry eye syndrome.
FDA Clears Dedicated Glaucoma Laser from Iridex
Iridex says its Cyclo G6™ Laser System is the first designed solely for use in treating glaucoma and its symptoms.
FDA Clears CenterVue’s EIDON Fully-Automated Retinal Imaging System
New retinal scanning technology means “what was once a dream, is now a reality.”
Successful Bionic Eye Trial Reported
A study into Bionic Vision Australia’s bionic eye implant has exceeded the expectations of its developers and has been presented at this week’s The Eye and the Chip World Congress on Artificial Vision.